East Lansing, MI · Founded 2018 · Privately Held (backing)
Operator of synthetic antigen-based vaccines designed to prevent and treat infectious diseases. Iaso Therapeutics is based in East Lansing, MI and was founded in 2018. Its last reported valuation was $5.3 million in Jan 2023. It has raised $1.8 million across 2 recorded rounds; the latest was a $570,000 seed round in Jan 2026.
Last reported valuation
$5.3M
Oct 2026
Priced at
—
Total raised
$1.8M
Last round
Seed Round
Jan 2026
Cap table — not yet on record
Iaso Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Iaso Therapeutics with a free account
·Watch Iaso Therapeutics: the Monday email on marks, rounds and moves
Where does Iaso Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Iaso Therapeutics's 2 recorded funding rounds.
